161 filings
8-K
CHRS
Coherus Biosciences Inc
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial ResultsĀ and Provides Current Business Update
4:16pm
8-K
CHRS
Coherus Biosciences Inc
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
CHRS
Coherus Biosciences Inc
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
CHRS
Coherus Biosciences Inc
5 Feb 24
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
8:09am
8-K
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
ukjmq8i r6mg
9 Jan 24
Results of Operations and Financial Condition
9:41pm
8-K
sgjeom ov00
9 Jan 24
Other Events
9:39pm
8-K
9xdwy
26 Dec 23
Other Events
8:49pm
8-K
vnq14
11 Dec 23
Departure of Directors or Certain Officers
4:13pm
8-K
p6guig aut9u
7 Dec 23
Departure of Directors or Certain Officers
5:16pm
8-K
gav7e1r3
27 Nov 23
Regulation FD Disclosure
4:03pm
8-K/A
97k0l3uezm0drwvfqw
13 Nov 23
Financial Statements and Exhibits
6:07am
8-K
2g1m00ivs78r a54xwq
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K/A
xpi20ttjrt4y4hsi
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
09s4ufokiw
27 Oct 23
Regulation FD Disclosure
4:19pm
8-K
s0ghmh
27 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
7i8tt01dbuo4oth5
6 Oct 23
Unregistered Sales of Equity Securities
5:03pm
8-K
ay4mu 23s53q
12 Sep 23
Entry into a Material Definitive Agreement
6:07am
8-K
vwnw1ihe
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:12am
8-K
85h qn1vzwruant
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm